Buy ACTEMRA 162 MG TOCILIZUMAB

ACTEMRA 162 MG is a subcutaneous solution containing tocilizumab, used for managing inflammatory conditions. This medication is designed to help reduce inflammation and improve symptoms.

Strength

162 MG

Pack Size

4 PFS

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ACTEMRA 162 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis. It works by targeting specific proteins in the body to reduce inflammation. This medication is often prescribed when other treatments have not been effective. People often ask, 'What is ACTEMRA used for?' and the answer is that it is used to manage symptoms of inflammatory conditions.

Side Effects

Common effects of ACTEMRA 162 MG may include injection site reactions, headache, and upper respiratory tract infections. Some users may also experience fatigue or nausea. These effects vary from person to person and are not experienced by everyone who uses this medication.

Precautions & Warnings

ACTEMRA 162 MG should be used with caution in individuals with a history of infections or liver problems. It is important to follow the advice of a healthcare provider regarding the use of this medication. Always store the solution properly to maintain its effectiveness.

Avoid Interactions

ACTEMRA 162 MG may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.

References

Frequently Asked Questions

ACTEMRA 162 MG is used to manage symptoms of inflammatory conditions such as rheumatoid arthritis.

ACTEMRA 162 MG is administered subcutaneously, typically by a healthcare provider.

Common side effects may include injection site reactions, headache, and upper respiratory tract infections.

It is important to consult a healthcare provider before using ACTEMRA 162 MG with other medications to avoid potential interactions.

ACTEMRA 162 MG should be stored according to the instructions provided by the manufacturer to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.